Status:
ACTIVE_NOT_RECRUITING
Study of AAV5-hFIX in Severe or Moderately Severe Haemophilia B
Lead Sponsor:
CSL Behring
Conditions:
Hemophilia B
Eligibility:
MALE
18+ years
Brief Summary
This is an open-label, extension study enrolling patients who have successfully completed all assessments in Study CT-AMT-060-01 (Years 1-5). Assessment phase will begin at Visit 36 (the first clinica...
Eligibility Criteria
Inclusion
- Subjects with congenital hemophilia B who completed Study CTAMT-060-01
- Able to provide informed consent following receipt of verbal and written information about the trial.
Exclusion
- Enrolled subjects will have already been assessed based on the exclusion criteria for Study CT-AMT-060-01.
Key Trial Info
Start Date :
March 18 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2026
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT05360706
Start Date
March 18 2021
End Date
May 1 2026
Last Update
August 26 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Vivantes Klinikum im Friedrichshain
Berlin, Germany
2
Universitaetsklinikum Frankfurt - Klinikum der Johann Wolfgang Goethe Universitaet
Frankfurt, Germany
3
Amsterdam UMC - Locatie AMC
Amsterdam, Netherlands
4
Groningen UMC
Groningen, Netherlands